CELSUS THERAPEUTICS PLC's ticker is CLTX and the CUSIP is 15119A202.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $166,000 | -23.9% | 286,508 | 0.0% | 0.02% | -35.3% |
| Q1 2015 | $218,000 | -84.9% | 286,508 | -4.5% | 0.03% | -84.7% |
| Q4 2014 | $1,440,000 | -3.4% | 300,000 | +22.7% | 0.22% | -27.7% |
| Q3 2014 | $1,491,000 | +133.3% | 244,500 | +137.4% | 0.31% | +81.7% |
| Q2 2014 | $639,000 | -4.3% | 103,000 | 0.0% | 0.17% | +9.7% |
| Q1 2014 | $668,000 | – | 103,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 286,508 | $166,000 | 0.02% |
| MORGAN STANLEY | 8 | $0 | 0.00% |
| UBS Group AG | 3,350 | $2,000 | 0.00% |
| Citadel Advisors | 15,249 | $9,000 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 600 | $348,000 | 0.00% |